Obesity: New and Emerging Strategies to Optimally Manage a Chronic Disease

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in weight loss. In this educational program, these experts review current guidelines for obesity management and recommendations for the use of currently approved obesity medications and provide insights into investigational agents that may increase health care professionals’ ability to personalize therapy.

This educational activity is an archive of a live virtual symposium held on June 5, 2026.

Target Audience

This educational activity is directed toward endocrinologists, diabetes specialists, dietitians, primary care physicians, nurse practitioners, physician assistants, and nurses. Other health care professionals involved in the care of patients with obesity are also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Outline guideline-recommended best practices for the management of obesity and associated comorbidities
• Evaluate clinical trial efficacy and safety data for current and emerging therapies for the management of obesity
• Implement recommended procedures to prevent, minimize, or manage adverse events associated with anti-obesity medications (AOMs)
• Design individualized, comprehensive, guideline-supported AOM-based treatment plans that optimize short- and long-term clinical outcomes while improving health-related quality of life in patients with obesity

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies.

PER^® mitigated all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Additional Disclaimers

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.

This accredited activity has been developed in accordance with applicable accreditation standards to ensure balance, independence, objectivity, and scientific rigor. Faculty were instructed to use generic names where possible and to base recommendations on the best available evidence.

In the context of clinical discussion, proprietary product names may be mentioned. Such references are made for educational purposes only and do not constitute endorsement of any commercial product or service.

Learners are encouraged to independently evaluate the information presented and apply their own clinical judgment when considering patient care decisions.

This activity may have used AI-assisted tools to support educational development. All content was reviewed and approved by qualified faculty or planners. The accredited provider retains full responsibility for accuracy, balance, and independence.